| Study | Platform | Patients | Diagnostic yield (%) | |
---|---|---|---|---|---|
No. | Phenotype | ||||
1 | Thienpont B, et al. (2007) [12] | 1Â Mb BAC/PAC | 60 | Syndromic CHD | 10(16.6%) |
2 | Richards AA, et al. (2008) [13] | Nimblegen 385Â K CGH | 20 | Syndromic CHD | 5 (25%) |
20 | Isolated CHD | 0 | |||
3 | Erdogan F, et al. (2008) [14] | tiling path BAC array | 105 | Isolated CHD | 4(3.8%) |
4 | Breckpot J, et al. (2010) [15] | 1Â Mb BAC/PAC | 90 | Syndromic CHD | 16(17.8%) |
5 | Goldmuntz E, et al. (2011) [16] | Affymetrix GeneChip 100Â K array | 58 | Syndromic CHD | 12(20.7%) |
6 | Breckpot J, et al. (2011) [17] | Affymetrix 6.0 array | 46 | Isolated CHD | 2 (4.3%) |
7 | Connor JA, et al. (2013) [18] | Not specified | 121 | Unselected CHD | 9 (7%) |
8 | Syrmou A, et al. (2013) [19] | Agilent 244Â K CGH array | 55 | Syndromic CHD | 29 (52.7%)a |
Agilent 4 × 180 K SNP + CGH array | |||||
9 | Our study | Same as above | 162 | Isolated CHD | 7 (4.3%) |
260b | Syndromic CHD | 47 (18.1%) |